Skip to main content
BBIO
NASDAQ Life Sciences

KKR Launches 5M Share Secondary Offering in BridgeBio, Company Gets No Proceeds

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$78.74
Mkt Cap
$15.876B
52W Low
$46.81
52W High
$93.415
52W Position info
68% above low
Off High info
16% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

BBIO sits 68% above its 52-week low of $46.81 on light trading volume (0.4× avg).

Summary

KKR Genetic Disorder L.P. sold 5 million shares of BridgeBio in a secondary offering, with the company receiving no proceeds. The offering priced at $78.00 per share, totaling $390 million, and was oversubscribed. It closed on August 17, 2026, at a net price of $77.415 per share to KKR Genetic Disorder L.P. After the sale, KKR's beneficial ownership fell to 4.7%, and it ceased to be a 5% owner. The sale came just weeks after BridgeBio raised $934 million in preferred equity and filed a $500 million ATM, signaling continued capital activity. The offering was led by William Blair, Goldman Sachs, and KKR, and was subject to market conditions. This followed the S-3ASR shelf filed on July 24, 2026, and added selling pressure from a major existing shareholder.

Updated with an SEC SCHEDULE 13D/A filing · What changed

Updates

  1. · SEC SCHEDULE 13D/A — The offering closed on August 17, 2026, at a net price of $77.415 per share to KKR Genetic Disorder L.P. After the sale, KKR's beneficial ownership fell to 4.7%, and it ceased to be a 5% owner.

  2. · GlobeNewswire — The offering priced at $78.00 per share, totaling $390 million, and is oversubscribed, with closing expected August 17.

At the time of this announcement, BBIO was trading at $78.74 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $15.9B. The 52-week trading range was $46.81 to $93.42. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

BBIO - Latest Insights

BBIO
Oct 29, 2026, 4:52 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $70.69
Real-time Price: $78.11 info
Change: +$7.42 (+10%) info
Market Cap: $15.231B info
BBIO
Oct 29, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $71.44
Real-time Price: $78.11 info
Change: +$6.67 (+9%) info
Market Cap: $15.231B info
BBIO
Oct 29, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $70.67
Real-time Price: $78.11 info
Change: +$7.44 (+11%) info
Market Cap: $15.231B info
BBIO
Oct 13, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $65.75
Real-time Price: $78.11 info
Change: +$12.36 (+19%) info
Market Cap: $15.231B info
BBIO
Oct 11, 2026, 2:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $65.35
Real-time Price: $78.11 info
Change: +$12.76 (+20%) info
Market Cap: $15.231B info